Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates LABP, WRK, TGAN, KAMN

WRK, TGAN, LABP

NEW YORK, NY / ACCESSWIRE / March 27, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Landos Biopharma, Inc. (NASDAQ:LABP)'ssale to AbbVie Inc. Under the terms of the proposed transaction, AbbVie would acquire Landos for $20.42 per share in cash upon closing, plus one non-tradable contingent value right per share with a value of up to $11.14 per share, subject to the achievement of a clinical development milestone. If you are a Landos shareholder, click here to learn more about your rights and options.

WestRock Company (NYSE:WRK)'s sale to Smurfit Kappa Group plc for one new Smurfit WestRock share and $5.00 in cash for each share of common stock of WestRock. Following completion of the proposed transaction, WestRock stockholders are expected to own approximately 49.6% of the combined company.If you are a WestRock shareholder, click here to learn more about your rights and options.

Transphorm, Inc. (NASDAQ:TGAN)'s sale to Renesas Electronics Corporation for $5.10 per share in cash. If you are a Transphorm shareholder, click here to learn more about your rights and options.

Kaman Corp. (NYSE:KAMN)'s sale to Arcline Investment Management, L.P. for $46.00 per share in cash. If you are a Kaman shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE: Halper Sadeh LLC



View the original press release on accesswire.com